Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

MX:GLPGN Stock Latest News

Company AnnouncementsLakefront Biotherapeutics Completes €2.85 Million Share Buyback Program1w ago

Company AnnouncementsLakefront Biotherapeutics Sells Cell Therapy Pipeline, Sharpens Focus on T-Cell Engagers2w ago
The FlyLakefront sells early-stage cell therapy pipeline to Armed Cell for $8M upfront2w agoLKFT
Company AnnouncementsLakefront Biotherapeutics Expands Share Buyback Amid Clinical-Stage Growth2w ago
Company AnnouncementsBank of America trims stake in Lakefront Biotherapeutics below 10% threshold3w ago

Lakefront Biotherapeutics Buys Back 117,437 Shares in Ongoing Repurchase Program

Company AnnouncementsLakefront Biotherapeutics Buys Back 117,437 Shares in Ongoing Repurchase Program3w ago

Company AnnouncementsLakefront Biotherapeutics Buys Back Over 100,000 Shares in Ongoing Program1M ago

The FlyMicrosoft upgraded, HubSpot initiated: Wall Street’s top analyst calls1M agoALV ARX

The FlyLakefront upgraded to Outperform from Sector Perform at RBC Capital1M agoLKFT
Company AnnouncementsLakefront Biotherapeutics Steps Up Share Buybacks as Autoimmune Pipeline Advances1M ago
Company AnnouncementsLakefront Biotherapeutics Expands Share Buyback Amid Strong Capital Position1M ago
Company AnnouncementsLakefront Biotherapeutics boosts buyback as it advances autoimmune pipeline1M ago

Lakefront Biotherapeutics Buys Back 127,796 Shares Under Ongoing Repurchase Program

Company AnnouncementsLakefront Biotherapeutics Buys Back 127,796 Shares Under Ongoing Repurchase Program2M ago

Company AnnouncementsLakefront Biotherapeutics Buys Back 117,000 Shares in Ongoing Repurchase Program2M ago

Company AnnouncementsBank of America Builds 10% Stake in Lakefront Biotherapeutics Under Belgian Transparency Rules2M ago

The FlyLakefront Biotherapeutics granted orphan drug designation for gamgertamig2M agoGILD LKFT
Company AnnouncementsLakefront Biotherapeutics Expands Share Buyback, Bolstering Capital Strategy2M ago
The FlyLakefront Biotherapeutics price target lowered to $26 from $30 at Morgan Stanley2M agoLKFT
Company AnnouncementsLakefront Biotherapeutics Boosts Immunology Push With Ouro Deal and Strong Cash Outlook2M ago

Is 0JXZ a Buy, Before Earnings?

Pre-EarningsIs 0JXZ a Buy, Before Earnings?2M ago

Company AnnouncementsLakefront Biotherapeutics Buys Back 97,497 Shares Under Ongoing Repurchase Program2M ago

Company AnnouncementsLakefront Biotherapeutics Buys Back 95,670 Shares Under Ongoing Repurchase Program3M ago